Explore

Rapid ReadRapid Read
HHS Unveils AI Initiatives to Accelerate U.S. Clinical Trials

HHS Unveils AI Initiatives to Accelerate U.S. Clinical Trials

The U.S. Department of Health and Human Services (HHS) has announced a new program and three complementary projects aimed at significantly speeding up clinical trials through the integration of artificial intelligence (AI), advanced computational models, and real-time analysis. The core initiative, named SURPASS (Simulation-augmented, Real-time Platform Adaptive Seamless Trials), seeks to develop AI-powered platforms that will continuously and adaptively support clinical trial designs. This program includes the creation of a phaseless design engine to simulate trials for faster results with fewer patients, a continuous inference engine for real-time data analysis and trial adaptations, and an agentic AI operations layer to automate startup activities and data collection. These efforts are part of a broader strategy by HHS to transform U.S. clinical trials, building on previous initiatives like Operation TrialBlazer and the FDA's pilot program using AI for real-time clinical trial data monitoring. The goal ...
TrendlineTrendline
Traditional Medicinals Opens New Manufacturing Facility in Franklin County, Virginia, Expanding Production and Local Employment

Traditional Medicinals Opens New Manufacturing Facility in Franklin County, Virginia, Expanding Production and Local Employment

Traditional Medicinals Opens New Manufacturing Facility in Franklin County, Virginia, Expanding Production and Local Employment
TrendlineTrendline
SereNeuro Therapeutics Secures Pre-Seed Financing to Advance Non-Opioid Pain Therapies

SereNeuro Therapeutics Secures Pre-Seed Financing to Advance Non-Opioid Pain Therapies

SereNeuro Therapeutics Secures Pre-Seed Financing to Advance Non-Opioid Pain Therapies
Rapid ReadRapid Read
FDA Approves Ameluz with Red-Light Photodynamic Therapy for Superficial Basal Cell Carcinoma

FDA Approves Ameluz with Red-Light Photodynamic Therapy for Superficial Basal Cell Carcinoma

The Food and Drug Administration (FDA) has approved Ameluz (aminolevulinic acid hydrochloride) gel in conjunction with red-light photodynamic therapy (PDT) for the treatment of superficial basal cell carcinoma (BCC) in adults. This marks the first FDA approval of a photodynamic therapy specifically for a skin cancer, expanding its use beyond actinic keratosis, a precancerous condition. Basal cell carcinoma is the most prevalent form of skin cancer, typically managed through surgical interventions. The newly approved non-surgical option involves a two-step in-office procedure. First, a gel containing aminolevulinic acid is applied to the lesion and surrounding skin, which is preferentially absorbed by abnormal cells, making them light-sensitive. Following an incubation period, the area is exposed to a red-light lamp, activating the medication and initiating a chemical reaction that damages and destroys the targeted cancerous cells. This method aims to treat the cancer without requiring incisions or skin rem...
Rapid ReadRapid Read
Long-Term Wearable Data Offers Personalized Approach to Defining Insufficient Sleep

Long-Term Wearable Data Offers Personalized Approach to Defining Insufficient Sleep

Researchers from the National University of Singapore (NUS) have introduced a personalized short sleep (pSS) framework, utilizing long-term data from wearable devices to define insufficient sleep on an individual basis. This new approach, published in 'Sleep Medicine,' moves beyond universal sleep cutoffs, such as the commonly used six-hour threshold. The study, which followed 462 working adults for up to a year using Oura Rings and daily smartphone assessments, sets a personalized threshold at one hour below an individual's 75th percentile of sleep duration. This percentile is considered an estimate of sleep obtained when occupational and social constraints are reduced. While the population average for short sleep remained similar between the conventional and personalized methods (around 35-37% of nights), the personalized approach identified different individuals and nights as experiencing insufficient sleep. For instance, a habitual short sleeper might consistently fall below six hours but not be consid...
The Commercial AppealThe Commercial Appeal
Access to GLP-1s Could Help Tackle TN Cardiovascular Crisis | Opinion

Access to GLP-1s Could Help Tackle TN Cardiovascular Crisis | Opinion

Obesity remains one of Tennessee's -- and the nation's -- most significant public health challenges.
Rapid ReadRapid Read
InvoGenix Advances AI-Powered Support for Independent Medical Practices

InvoGenix Advances AI-Powered Support for Independent Medical Practices

InvoGenix, an artificial intelligence tool developed by a multidisciplinary student team at the University of Illinois Urbana-Champaign, is moving closer to clinical implementation. This innovation aims to reduce the administrative burden on physicians, particularly in small, independent, and rural medical practices, by making advanced health technology accessible. The tool converts key data from patient-physician interactions into structured, customizable clinical notes and relevant diagnostic and treatment codes. This addresses persistent challenges in healthcare, such as time-consuming documentation and medical billing complexities, which can lead to lost revenue and inaccuracies, especially for practices with limited resources. InvoGenix is designed to be cost-effective and EHR-agnostic, allowing clinics to integrate it without needing to overhaul existing electronic health record systems. The system generates clinical notes in the standard SOAP format and recommends billing codes, with physicians reta...
TrendlineTrendline
PetPace Launches AI-Powered Smart Health Monitoring Collar at Chewy

PetPace Launches AI-Powered Smart Health Monitoring Collar at Chewy

PetPace Launches AI-Powered Smart Health Monitoring Collar at Chewy
TrendlineTrendline
Smart Rings Emerge as Discreet Wearable Technology for Health and Wellness Tracking

Smart Rings Emerge as Discreet Wearable Technology for Health and Wellness Tracking

Smart Rings Emerge as Discreet Wearable Technology for Health and Wellness Tracking
Rapid ReadRapid Read
WHO Coined 'Disease X' as Hypothetical Pandemic Threat, CEPI Proposes AI-Powered Preparedness Engine

WHO Coined 'Disease X' as Hypothetical Pandemic Threat, CEPI Proposes AI-Powered Preparedness Engine

The World Health Organization (WHO) introduced the term 'Disease X' in its 2018 Research & Development Blueprint for Epidemics to represent a hypothetical pathogen with pandemic potential for which no countermeasures currently exist. This concept is part of a broader effort to prepare for future global health crises, building on lessons learned from events like the COVID-19 pandemic. The Coalition for Epidemic Preparedness Innovations (CEPI) is actively working on strategies to address this threat, including the development of a 'Pandemic Preparedness Engine for Disease X.' This proposed tool aims to integrate fragmented knowledge bases, such as genomic sequences, to facilitate the rapid development of vaccines and medical interventions. The initiative leverages artificial intelligence (AI) to analyze potential pathogens, predict mutations, and design vaccine sequences, thereby accelerating the response to emerging infectious diseases. CEPI's work focuses on the 25 known families of viruses that can infect...
Rapid ReadRapid Read
Bismarck-Burleigh Public Health Offers Free Narcan Training to Combat Opioid Overdoses

Bismarck-Burleigh Public Health Offers Free Narcan Training to Combat Opioid Overdoses

Bismarck-Burleigh Public Health recently hosted a free Narcan training session, providing participants with essential knowledge on how to administer the medication and recognize the signs of an opioid overdose. Narcan is a critical medication that can temporarily restore breathing in individuals experiencing an overdose from fentanyl or other opioids. Attendees of the training received free Narcan kits, drug disposal pouches, and opioid emergency boxes. Sue Kahler, an employee with Bismarck-Burleigh Public Health, emphasized the importance of identifying overdose warning signs such as pale, clammy skin, unconsciousness, unresponsiveness, and a low or absent heartbeat. Organizations interested in this vital training can book sessions through Bismarck-Burleigh Public Health.
TrendlineTrendline
Consumer Sleep Trackers Offer General Sleep Insights but Lack Clinical Accuracy

Consumer Sleep Trackers Offer General Sleep Insights but Lack Clinical Accuracy

Consumer Sleep Trackers Offer General Sleep Insights but Lack Clinical Accuracy